Mettler-Toledo International (NYSE:MTD – Get Free Report) and iRadimed (NASDAQ:IRMD – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership and analyst recommendations.
Profitability
This table compares Mettler-Toledo International and iRadimed’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mettler-Toledo International | 21.40% | -622.80% | 24.97% |
| iRadimed | 27.36% | 24.48% | 21.25% |
Analyst Recommendations
This is a breakdown of recent ratings for Mettler-Toledo International and iRadimed, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mettler-Toledo International | 0 | 6 | 7 | 0 | 2.54 |
| iRadimed | 0 | 1 | 3 | 1 | 3.00 |
Valuation and Earnings
This table compares Mettler-Toledo International and iRadimed”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mettler-Toledo International | $4.03 billion | 5.19 | $869.19 million | $42.64 | 24.24 |
| iRadimed | $86.28 million | 12.81 | $22.48 million | $1.83 | 47.23 |
Mettler-Toledo International has higher revenue and earnings than iRadimed. Mettler-Toledo International is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 92.3% of iRadimed shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by company insiders. Comparatively, 36.8% of iRadimed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Risk and Volatility
Mettler-Toledo International has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, iRadimed has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500.
Summary
iRadimed beats Mettler-Toledo International on 8 of the 15 factors compared between the two stocks.
About Mettler-Toledo International
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company’s retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.
About iRadimed
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
